BRKR Bruker Corporation

62.10USD-1.83%Mkt Cap: 9.48B USDP/E: —

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instrument…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap9.48B USD
Enterprise Value11.34B USD
Revenue (TTM)3.51B USD
Gross Profit1.58B USD
Net Income (TTM)-8.60M USD
Revenue/Share23.07 USD
Last Price62.10 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees11.1K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)25.58
PEG1.52
EV/EBITDA20.59
EV/Revenue3.23
P/S2.70
P/B4.15
EPS (TTM)-1.12 USD
EPS (Forward)2.45 USD
52W Range
32.3781% of range68.98
52W High68.98 USD
52W Low32.37 USD
Profitability
Gross Margin45.91%
Oper. Margin9.17%
EBITDA Margin15.68%
Profit Margin-0.25%
ROE-0.35%
ROA-0.14%
ROIC2.77%
ROCE4.76%
Growth
Revenue Growth1.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF134.10M USD
CapEx (TTM)120.20M USD
FCF Margin5.82%
FCF Yield2.15%
Net Debt1.62B USD
Net Debt/EBITDA2.94
Net Debt/FCF7.92
Balance Sheet
Debt/Equity0.83
Current Ratio1.84
Quick Ratio0.78
Book Value/Sh14.97 USD
Cash/Share0.78 USD
Dividends
Fwd Div Rate0.20 USD
Trail. Div Rate0.05 USD
Div. Yield0.32%
5Y Avg Yield0.32%
Payout Ratio38.46%
Ex-Div DateSep 21, 2026
Pay DateOct 7, 2026
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)68.00 USD
Upside (mean)+9.5%
Target Range55.00 USD – 85.00 USD
55.00+9.5% to mean85.00
# Analysts12
Ownership
Shares Out.152.72M
Float104.05M
Insiders26.90%
Institutions90.84%
Short Interest
Short Ratio5.1d
Short % Float14.17%
Short % Out.7.37%
Shares Short11.25M
Short (prev mo.)12.41M
Technical
SMA 5059.53 (+4.3%)
SMA 20050.90 (+22.0%)
Beta1.27
S&P 52W Chg12.08%
Avg Vol (30d)2.39M
Avg Vol (10d)3.14M
Technical Indicators
RSI (14)53.0
MACD0.8712
MACD Signal0.7212
MACD Hist.+0.1500
BB Upper66.12 USD
BB Middle60.67 USD
BB Lower55.22 USD
BB Width17.97%
ATR (14)3.608 USD
Vol Ratio (20d)0.72x

About Bruker (NASDAQ: BRKR)

›

Bruker (NASDAQ: BRKR) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 11,085 employees.

The shares were at 62.10 USD on 19 November 2026, up 55.9% over 52 weeks. Its 52-week range is 32.37 USD to 68.98 USD: the price is 10.0% below the high and 91.8% above the low.

Its market capitalisation is 9.48B USD. It pays a dividend yielding 0.32% (it pays out 38% of its earnings), against a median of 2.36% among the dividend payers in that peer group.

Bruker reports return on equity of -0.4%, an operating margin of 9.2% and revenue up 1.6% year over year.

Its debt exceeds its cash by 1.62B USD, a debt-to-equity ratio of 0.83. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 12 analysts cover the stock, with an average rating of Buy; their mean price target of 68.00 USD is 9.5% above the current price. The next earnings report is expected on 11 February 2027.